|
|
| 2.35 Delayed Data As of Feb 27 |  -0.0499 / -2.08%Today’s Change | 1.55 Today|||52-Week Range 5.04 | +18.69% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $28.0M |
XTL Biopharmaceuticals Ltd. Herzliya Business Park Herzliya -- 46766 |
| Other institutional | 0.83% |
| Mutual fund holders | 0.27% |
| Individual stakeholders | -- |
| Joshua Levine | Chief Executive Officer |
| David Kestenbaum | Chief Financial Officer |
| Moshe Mittelman | Medical Director |
| Daniel Shapira | Internal Auditor |
| Navon Shalom | Controller |
